Orthopedic companies thrive by creating moats—strategic advantages that protect their market position and fuel growth.
Like the moats around medieval castles, these can serve as both defensive barriers to fend off competitors and offensive tools to capture market share. As George Savile, 1st Marquess of Halifax, noted: “Moats can be both defensive and offensive weapons. In defense, they force enemies to attack at your strongest point. Offensively, they free up resources for bold moves against competitors. Great moats provide flexibility in strategy.”
Here are 10 key moats orthopedic companies leverage today, ranked from strongest to weakest. This is my take—let me know your thoughts at editor@orthostreams.com.
1. Customer Access (Top Moat)
Large orthopedic companies (“Big Orthos”) dominate through exclusive hospital supplier contracts or capital-intensive robot purchase agreements. These lock in access to hospitals and ASCs, creating a formidable barrier for smaller players (“ortho minnows”).
2. Regulatory Clearances
Class III regulatory approvals are a powerful per-product moat. These high-barrier clearances can take over a decade and $100M in clinical trials to achieve, offerin...
